Quinine with tetracycline for the treatment of drug-resistant falciparum malaria in Thailand by Watt, George et al.
Am. I. Trop. Me@ Hyg.. 47(1), 1992, pp. 108â€”1 I
Copyright C 1992 by The American Society ofTropical Medicine and Hygiene
QUININE WITH TETRACYCLINE FOR THE TREATMENT OF
DRUG-RESISTANT FALCIPARUM MALARIA IN THAILAND
GEORGE WATF, LERSAN LOESUTTIVIBOOL, G. DENNIS SHANKS, ELLEN F.
BOUDREAU, ARTHUR E. BROWN, KATCHRINNEE PAVANAND, H. KYLE WEBSTER,
AND SUWIT WECHGRITAYA
Armed Forces Research Institute ofMedical Science, Bangkok, Thailand; Royal Thai Army
Hospital, Aranyaprathet, Thailand
Abstract. Reports ofdeteriorating quinine efficacy prompted us to investigate the ability
ofquinine-tetracycline to clear parasites and feverfrom patientswith multiple drug-resistant
Plasmodium fakiparum infections. Past and present treatment results were compared at
two study sites along the Thai-Cambodian border. In northeastern Thailand, quinine
tetracycline cleared parasites more quickly in 1990 than in 1987 (mean 3.4 and 4.0 days,
respectively; P = 0.006). In southeastern Thailand, there were no significant differences
between 1990 (n = 26) and 1981â€”1983 (n = 42) in the time taken to clear either parasites
(median 96 and 93 hr,respectively;P = 0.35)or fever(mean 74 and 66 hr,respectively;
P = 0.30). In vitro drug sensitivity testing revealed a two-fold decrease in susceptibility to
quinine between 1983 and 1990 in isolates from the southeastern Thai-Cambodian border
(mean inhibitory concentration 166 ng/ml and 320 ng/ml, respectively; P < 0.001). We
conclude that oral quinine-tetracycline continues to reliably clear parasites and fever from
falciparum malaria patients infected in eastern Thailand. Periodic re-evaluations are war
ranted, however, since the decrease in in vitro susceptibility to quinine may be followed
by an in vivo decay in the treatment response.
Resistance to quinine has increased steadily in
Southeast Asia. When administered alone, qui
nine cured over 90% of the patients at the Bang
kok Hospital for Tropical Diseases in 1976, but
the cure rate had decreased to 80% in 1980 and
to only 60% in 1986.' Patients in whom quinine
failed to control parasitemia have been report
ed,23and ithas been suggestedthatadvancing
quinine resistance could lead to untreatable fal
ciparum malaria.4 Despite these worrisome re
ports, quinine-tetracycline remains the standard
treatment for adults hospitalized with uncom
plicated falciparum malaria in much of South
east Asia. Therefore, we prospectively evaluated
this drug combination in Thailand, and com
pared our results with those obtained during the
treatment of comparable patients three and sev
en years ago to assess a possible decrease in ef
ficacy.
PATIENTSAND METHODS
Southeastern Thailand-in vivo
A one-week course of quinine sulfate (650 mg
orally every 8 hr) and tetracycline hydrochloride
(250 mg orally every 6 hr) was given to prey
ously untreated members ofthe Thai militia ad
mitted to Aranyaprathet Army Hospital with un
complicated falciparum malaria in 1990. Other
malaria trials were being conducted concurrent
ly, and recruitment of patients into this inves
tigation ofquinine ended when the other studies
ended. Standard thick and thin blood films were
examined for Plasmodium fakiparum parasites
twice a day and the patients were discharged when
symptoms had resolved and no asexual parasites
were seen in 200 microscopic fields on two suc
cessive smears. The remainder of the one-week
treatment course, to be completed after dis
charge, was given to the patients upon leaving
the hospital.
The parasite clearance time was the number
of hours between the fIrst dose of medication and
the first of two successive blood films that were
negative for P. fakiparum. Oral temperatures
were taken even four hours during the day and
every eight hours at night. The fever clearance
time was the number of hours from the first dose
of medication to the point at which the patient
became and remained afebrile (< 37.2Â°C).
The parasite and fever clearance times mea
sured in 1990 were compared with values ob
tamed during studies of quinine-tetracycline
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conductedfrom 1981 to 1983.The 1981â€”1983
study subjects were members ofthe Thai militia
who acquired their falciparum infections along
the same part of the southeastern Thai-Cam
bodian border. Parasite counts in both studies
were performed by the same technicians; the same
nurses administered medication and recorded
temperature data. The study hospital in 1990 was
50 km from that in the 1981â€”1983 investigation.
The 1981â€”1983 treatment regimen differed in
that a dosage ofSOO mg oftetracycline was given
three times a day for six days instead of 250 mg
four times a day for seven days.
Southeastern Thailand-in vitro
Falciparum parasites isolated from the 1990
study patients were tested for in vitro sensitivity
to quinine using a microdilution radioisotope
method.5 The 50% inhibitory concentration (IC50)
of quinine was the drug concentration at which
there was a 50% decrease in 3H-labeled hypo
xanthine uptake by parasites. In vitro suscepti
biity to quinine was also determined by the ra
dioisotope method in isolates obtained from Thai
soldiers infected in southeastern Thailand during
a 1983 halofantrine treatment trial.6
Northeastern Thailand
Parasiteclearancetimes were calculatedfor
members of the Thai militiadmittedto a re
search station in northeastern Thailand with un
complicated falciparum malaria. Patients were
given a supervised seven-day course of quinine
at a dosage of 650 mg three times a day and
tetracyclineata dosageof 250 mg fourtimesa
day;thickbloodfilmswereexamined daily.Data
from 50 consecutivepatientsadmittedin 1987
and from 50 consecutive patients admitted in
1990wereanalyzed.Parasiteclearancetimeswere
expressedindaysratherthanhoursbecausethick
blood filmswere only examined once a day.
Clearancetimesduringthistwo-yearperiodwere
compared for all patients with admission counts
of > 1,000 parasitizederythrocytes/mm3of
blood.
Statistical analysis
Normally distributed values were compared
using the Student's t-test. Values that were not
normally distributed were compared using the
Mann-Whitney U test,and nonparametric95%
confidence intervals were determined using a
nonlinear interpolation formula.7 Two-tailed tests
of significance were calculated in all cases.
RESULTS
Southeastern Thailand
Twenty-six men with a median age of24 years
were investigated prospectively in 1990, and 42
men with a median age of 22 years were studied
in 1981â€”1983. The two groups ofpatients were
comparable with respect to both mean pretreat
ment parasitemia (29, 661 in 1990 and 23, 754
in 1981â€”1983; P > 0.l)and to previous malaria
infections; approximately two-thirds of the sol
diers from both studies had a history of malaria
(median 1â€”3episodes).
Quinine-tetracycline cleared parasites and fe
ver in all cases from both the 1981â€”1983 and
1990 groups. Parasite clearance times were not
normally distributed. Both the median parasite
clearance time (96 hr in 1990, range 45â€”193; 93
hr in 1981â€”1983,range36-121)and the mean
fever clearance time (74 hr in 1990, range 5â€”
127;66 hr in 1981â€”1983,range 13â€”116)were
slightly longer in 1990 (Figure 1), but the differ
ences were not significant. Parasites from this
region became significantly less susceptible to
quinine in vitro. The mean IC50 ofthe 22 isolates
tested in 1990 (320 ng/ml, range 147â€”556) was
twice that ofthe 15 isolates tested in 1983 (166
ng/ml, range 48â€”361; P < 0.00 1) (Figure 1).
Northeastern Thailand
The 50 male soldiers treated in 1987 were
demographically similar to the 50 treated in 1990.
Among the 50 patients, 43 in each group had an
admission count of > 1,000 parasitized eryth
rocytes/mm3 ofblood. The initial parasite counts
in these 43 patients were not normally distrib
uted. The median count in 1987 (8,065/mm3)
was not significantly different from that in 1990
(8, 364/mm3) (P> 0.1). The parasite clearance
timeswerenormallydistributed;themean num
ber of days to clearance in 1990 (3.4, range 2â€”
6) was significantly shorter than the clearance
time in 1987 (4.0, range 2â€”6;P < 0.001) (Fig
ure 1).
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Fioui@ 1. Response of Plasmodium falciparum from southeast Thailand (bottom) and northeast Thailand
(top) to quinine-tetracycline, and in vitro quinine sensitivity (bottom right). The upper and lower 95% confidence
intervals form the top and bottom of each column. The horizontal lines represent mean values, except for the
median parasite clearance times from southeast Thailand. Parasite clearance times from northeast Thailand
were significantly shorter in 1990 than in 1987. Parasites from southeast Thailand were significantly less sus
ceptible to quinine in 1990 than in 1983. IC@= 50% inhibitory concentration.
1990, but there was no evidence ofa substantial
reduction in the initial parasitologic or clinical
response to treatment between 1981â€”1983 and
l990(Figure 1). Parasite and feverclearance times
from patients infected on the southeastern bor
der were comparable to those measured seven
years earlier, while in the northeastern region,
parasites were cleared more rapidly in 1990 than
in 1987 (P = 0.006).
Further evidence that falciparum parasites from
the Thai-Cambodian border are highly drug-re
sistant, but can be eradicated by quinine-tetra
cycline is provided by results of recent investi
gations of the antimalarial activity of
fluoroquinolone antibiotics.'Â°â€•Relatively drug
sensitive Indian strains of P. fakiparum were
promptly eradicated by the fluoroquinolone an
DISCUSSION
The border regions of Thailand, particularly
the eastern border with Cambodia, are noted for
a high prevalence of multiple-drug resistant
strains of P.fakiparum.5 The ever expanding list
of antimalarials that can no longer be relied upon
to clear parasites acquired in this region now
includes chloroquine,8 sulfadoxine-pyrimetham
inc (FansidarÂ®),5 mefloquine-sulfadoxine-pyri
methamine,9 quinine alone, and halofantrine at
its recommended dose for semi-immune indi
viduals (three 500-mg doses; Ter Kuile F, un
published data). Given this gloomy situation, our
results are encouraging. Not only did the com
bination of quinine and tetracycline clear para
sites and fever in every patient we treated in
983
987
1990
P=0.000l
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tibiotic norfioxacin,'Â° but in southeastern Thai
land, parasitemia increased steadily to three times
its initial value during treatment with maximum
doses of ciprofloxacin. â€˜â€ Q˜uinine-tetracycline
promptly cleared parasites and resolved symp
toms in the ciprofioxacin treatment failures.
Optimism generated by these findings must be
tempered by two reservations. First, there was
no extended followup period in this study, so
that recrudescent infections would not have been
detected. Second, the quinine IC50 values mea
sured in 1983 already reflected resistance5 and
doubled during the subsequent seven years.
Chongsuphajaisiddhi and others have also dem
onstrated a gradual decrease in quinine suscep
tibility among Thai strains of P. fakiparum.'2
Although quinine is only one component of the
treatment regimen, steadily decreasing in vitro
susceptibility and the high IC50 values for qui
nine suggest that a deterioration of clinical re
sponse to quinine-tetracycline may occur in the
future. Therefore, periodic re-evaluations of the
efficacy of this combination must be made and
there remains an urgent need for new antima
larials.
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